BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

By P. Soares, V. Trovisco, A. Rocha, Jorge Lima, P. Castro, A. Preto, V. Máximo, Tiago Botelho, R. Seruca, M. Sobrinho-Simões. Oncogene, 2003

696 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/2fdbbfa2da87bd2c1b68e41b2fd44968997b11e3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Y. Nikiforov

In Oncology

1. Trey Ideker
2. John N. Weinstein
3. Christopher Sander
4. Nikolaus Schultz
5. Peter W. Laird
6. Charles M. Perou
7. Gad Getz
8. Giovanni Ciriello

In Pathology and Forensic Medicine

1. John N. Weinstein
2. Peter W. Laird
3. S. Baylin

Citations in the corpus

• Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014, background): “These mutations are almost always mutually exclusive (Soares et al., 2003), suggesting similar or redundant downstream effects.”